Press / media

As an institution of application-oriented research, the Fraunhofer Institute for Cell Therapy and Immunology IZI attaches great importance to informing customers and the public.

Latest press releases

19.5.2020

Patented Fraunhofer IZI technology facilitates specific Dengue virus diagnostics

A new technology developed by the Fraunhofer Institute for Cell Therapy and Immunology (IZI) facilitates a specific, sensitive diagnosis of the Dengue virus. The patented procedure has been licensed to two companies and corresponding antibody tests are now available on the market. As a result, both the four different Dengue virus serotypes can be differentiated and also the Dengue virus itself can be distinguished from other closely related flaviviruses, which include the yellow fever virus and tick-borne encephalitis virus, in addition to the Zika virus and the West Nile virus. Moreover, work is already underway to adapt the procedure to the SARS-CoV-2 virus and the West Nile virus.
Read more

5.5.2020

Professor Ulrich Demuth appointed to the German Ethics Council

On 23 April 2020, Professor Ulrich Demuth was elected to the German Ethics Council by the Bundestag. He was then formally appointed by President of the Bundestag, Dr Wolfgang Schäuble, on 30 April 2020. At present, Professor Demuth works for the Fraunhofer Institute for Cell Therapy and Immunology (IZI) in an advisory capacity. Until January 2020, he headed the Fraunhofer IZI Branch of Bioanalytics and Bioprocesses at the Potsdam-Golm site and ran the Fraunhofer IZI Drug Design and Target Validation Department in Halle (Saale), which he set up in 2013.
Read more

4.5.2020

From excellent science to application – with the SaxoCell innovation project in the BMBF competition "Clusters4Future"

They want to make better use of the body's self-healing powers and make "living drugs" available to many patients: Scientists from the TU Dresden, the University of Leipzig, and the Fraunhofer Institute for Cell Therapy and Immunology IZI have started the conception phase in their joint cluster SaxoCell in the innovation competition "Clusters4Future" of the Federal Ministry of Education and Research (BMBF). The SaxoCell project has started on May 1st 2020 and was selected as one of 16 out of 137 proposals for funding of the first concept phase in 2020.
Read more

28.4.2020

Pathogen of Q fever detected in the feces of ticks

Researchers from the Fraunhofer Institute for Cell Therapy and Immunology IZI were able to prove that ticks transmit the Q fever pathogen. Tick feces, which contain high concentrations of the bacteria, play a particularly important role in this process.
Read more

Archive press releases

RSS Newsfeed

Get the latest news about the Fraunhofer IZI. Through our RSS-feed you have the opportunity to follow all our press releases and receive them right when they are published.

Social media

 

Media library

 

Events